Cite
MLA Citation
Bram Verstockt et al.. “Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates.” Journal of Crohn's and colitis, vol. 13, 2019, pp. 864–872. http://access.bl.uk/ark:/81055/vdc_100092355426.0x00000f